Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

9
Number of overlapping holdings
39.1%
% of PPH's 26 holdings also in PJP
31.0%
% of PJP's 29 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PPH |
Weight in PJP |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 11.3% | 5.2% | 5.2% | |
ABBVIE INC | 6.2% | 5.0% | 5.0% | |
JOHNSON & JOHNSON | 6.4% | 4.9% | 4.9% | |
MERCK & CO. INC. | 4.3% | 5.0% | 4.3% | |
PFIZER INC | 4.2% | 4.8% | 4.2% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to PJP
ELI LILLY & CO | 6.2% | |
NOVARTIS AG-ADR | 5.6% | |
CENCORA INC | 5.3% | |
MCKESSON CORP | 5.1% | |
NOVO-NORDISK A/S-SPONS ADR | 5.1% | |
TEVA PHARMACEUTICAL-SP ADR | 5.0% | |
ASTRAZENECA PLC-SPONS ADR | 5.0% | |
GLAXOSMITHKLINE PLC-SPON ADR | 4.9% | |
ZOETIS INC | 4.9% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.6% |
PPH Underweight Relative to PJP
AMGEN INC | -5.1% | |
GILEAD SCIENCES INC | -5.0% | |
ABBOTT LABORATORIES | -4.9% | |
OCULAR THERAPEUTIX INC | -3.5% | |
INNOVIVA, INC. | -3.0% | |
BIOSANTE PHARMACEUTICALS INC | -2.8% | |
HARMONY BIOSCIENCES HOLDINGS, INC. | -2.8% | |
TARSUS PHARMACEUTICALS, INC. | -2.8% | |
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.8% | |
LIGAND PHARMACEUTICALS-CL B | -2.8% |